SHULMAN JOHN D 4
4 · Petros Pharmaceuticals, Inc. · Filed Oct 21, 2021
Insider Transaction Report
Form 4
SHULMAN JOHN D
Director10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2021-10-18$1.72/sh+1,661,807$2,849,999→ 5,057,771 total(indirect: See Footnote) - Purchase
Warrant
2021-10-18+1,661,807→ 1,661,807 total(indirect: See Footnote)Exercise: $1.72From: 2021-10-18Exp: 2026-10-18→ Common Stock (1,661,807 underlying)
Footnotes (2)
- [F1]See Note (1) in Exhibit 99.1.
- [F2]Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC ("MT") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT.